A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)
- Status
- RECRUITING
- Phase
- PHASE2/PHASE3
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Efficacy and Safety of Cladribine in Combination With CAG in Newly Diagnosed Unfit Patients With AML
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Azacitidine Combined With Homoharringtonie Based Regimens in AML
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome
- Status
- RECRUITING
- Phase
- PHASE1
IDH1/2 Mutational Analysis in AML Patients: Diagnosis and Follow-up
- Status
- COMPLETED
- Phase
- N/A
Galinpepimut-S Versus Investigator's Choice of Best Available Therapy for Maintenance in AML CR2/CRp2
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Safety Study of SEA-CD70 in Patients With Myeloid Malignancies
- Status
- RECRUITING
- Phase
- PHASE1
NK Cell Infusion for Patients With Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- PHASE1
Chimeric Antigen Receptor T-cells for The Treatment of AML Expressing CLL-1 Antigen
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
PHF19 Gene Expression and EZH2 Gene Deletion in Acute Myeloid Leukemia
- Status
- UNKNOWN
- Phase
- N/A
BLAST MRD AML-1: BLockade of PD-1 Added to Standard Therapy to Target Measurable Residual Disease in Acute Myeloid Leukemia 1- A Randomized Phase 2 Study of Anti-PD-1 Pembrolizumab in Combination With Intensive Chemotherapy as Frontline Therapy in Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Natural Killer Cells Infusion for Treating Acute Myeloid Leukemia Patients With Minimal Residual Disease
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
CPX-351 or CLAG-M Regimen for the Treatment of Acute Myeloid Leukemia or Other High-Grade Myeloid Neoplasms in Medically Less-Fit Patients
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE2
Reduced Intensity Flu/Mel/TBI Conditioning for HAPLO HCT Patients With Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Addition of an Anti-cancer Drug, Navtemadlin, to the Usual Treatments (Cytarabine and Idarubicin) in Patients With Acute Myeloid Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Decitabine, Venetoclax, and Ponatinib for the Treatment of Philadelphia Chromosome-Positive Acute Myeloid Leukemia or Myeloid Blast Phase or Accelerated Phase Chronic Myelogenous Leukemia
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Investigating Integrative Therapies for Symptom Management in Adults With Acute Leukemia
- Status
- TERMINATED
- Phase
- NA
TEAM-Trial: Targeting Epigenetic Therapy Resistance in AML With Bortezomib
- Status
- COMPLETED
- Phase
- PHASE2
Randomised Study of Oral Azacitidine vs Placebo Maintenance in AML or MDS Patients After Allo-SCT
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3